Risk of tumor lysis syndrome in patients with acute myeloid leukemia treated with venetoclax-containing regimens without dose ramp-up

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Ann Hematol
Asıl Yazarlar: Shahswar, Rabia, Beutel, Gernot, Gabdoulline, Razif, Koenecke, Christian, Markel, Dominik, Eder, Matthias, Stadler, Michael, Gohring, Gudrun, Schlegelberger, Brigitte, Trummer, Arne, Krauter, Juergen, Thol, Felicitas, Heuser, Michael
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer Berlin Heidelberg 2020
Konular:
Letter to the Editor
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7817590/
https://ncbi.nlm.nih.gov/pubmed/32705308
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00277-020-04181-5
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller